In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Anavex Life Sciences Corporation’s stock clocked out at $8.59, down -1.60% from its previous closing price of $8.73. In other words, the price has decreased by -$1.60 from its previous closing price. On the day, 0.62 million shares were traded.
Ratios:
To gain a deeper understanding of AVXL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.45 and its Current Ratio is at 9.45. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.
On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40.
On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 14 ’24 when Donhauser Peter D.O. bought 2,835 shares for $3.64 per share. The transaction valued at 10,319 led to the insider holds 5,000 shares of the business.
Thomas Steffen bought 5,000 shares of AVXL for $22,600 on May 15 ’24. The Director now owns 5,000 shares after completing the transaction at $4.52 per share. On Mar 28 ’24, another insider, MISSLING CHRISTOPHER U, who serves as the President and CEO of the company, sold 73,380 shares for $5.11 each. As a result, the insider received 374,972 and left with 1,250,210 shares of the company.
Stock Price History:
Over the past 52 weeks, AVXL has reached a high of $14.44, while it has fallen to a 52-week low of $3.25. The 50-Day Moving Average of the stock is -11.69%, while the 200-Day Moving Average is calculated to be 23.77%.
Shares Statistics:
A total of 84.99M shares are outstanding, with a floating share count of 82.47M. Insiders hold about 3.05% of the company’s shares, while institutions hold 34.49% stake in the company.
Earnings Estimates
A detailed examination of Anavex Life Sciences Corporation (AVXL) is currently in progress, with 1.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.18 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.69 and -$0.69 for the fiscal current year, implying an average EPS of -$0.69. EPS for the following year is $2.22, with 2.0 analysts recommending between $5.11 and -$0.66.
